Activation of the Androgen Receptor by Intratumoral Bioconversion of Androstanediol to Dihydrotestosterone in Prostate Cancer

The androgen receptor (AR) mediates the growth of benign and malignant prostate in response to dihydrotestosterone (DHT). In patients undergoing androgen deprivation therapy for prostate cancer, AR drives prostate cancer growth despite low circulating levels of testicular androgen and normal levels...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Mohler, James L., Titus, Mark A., Bai, Suxia, Kennerley, Brian J., Lih, Fred B., Tomer, Kenneth B., Wilson, Elizabeth M.
Format: Artigo
Jezik:Inglês
Izdano: 2011
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3075600/
https://ncbi.nlm.nih.gov/pubmed/21303972
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-10-1343
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki